2 results match your criteria: "Alfiero and Lucia Palestroni MS Comprehensive Care Center at Holy Name Medical Center[Affiliation]"
Antibody response to SARS-CoV-2 vaccination following typical and three-dose dosing schedules in multiple sclerosis patients treated with disease modifying therapies.
Mult Scler Relat Disord
July 2022
Alfiero and Lucia Palestroni MS Comprehensive Care Center at Holy Name Medical Center, Teaneck, NJ, USA.
Background: Immunizations against SARS-CoV-2 virus are now available and recommended, but the effect of additional dosing of the vaccine in immunocompromised MS patients is unknown.
Methods: Part I - A retrospective chart review of MS patients who were vaccinated against SARS-CoV-2 and tested commercially for Sars Covid Spike Protein Antibody between March 1 - June 30, 2021. Part II - Patients on treatment with anti-CD20 infusion medications who received a SARS-CoV-2 third mRNA vaccination dose August 13, 2021 - October 31, 2021 and were subsequently commercially tested for Sars Covid Spike Protein Antibody.
The presence of SARS-CoV2 antibodies in MS patients.
Mult Scler Relat Disord
May 2021
Alfiero and Lucia Palestroni MS Comprehensive Care Center at Holy Name Medical Center, 718 Teaneck Rd., Teaneck, NJ 07666, USA.
Background: The COVID-19 pandemic has raised novel concerns for people living with MS regarding their safety.
Methods: Observational study of patients at a single comprehensive community MS center.
Results: 48 patients with MS were suspected of developing COVID-19 March to May 2020; 2 died.